R. Townsend
Amministratore Delegato presso LEXEO THERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 30/04/2024
Profilo
R.
Nolan Townsend is currently the Chief Executive Officer & Director at Lexeo Therapeutics, Inc., the Director at Biotechnology Innovation Organization, and the Director at Arbor Biotechnologies, Inc. Previously, he served as the Chairman at Life Science Cares New York from 2022 to 2024 and as a Principal at Pfizer Inc. from 2008 to 2020.
He completed his undergraduate degree at the University of Pennsylvania in 2002 and earned an MBA from Harvard Business School in 2007.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
LEXEO THERAPEUTICS, INC.
0.64% | 13/05/2024 | 170 695 ( 0.64% ) | 2 M $ | 30/04/2024 |
Posizioni attive di R. Townsend
| Società | Posizione | Inizio |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Amministratore Delegato | 01/01/2020 |
Arbor Biotechnologies, Inc.
 Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 01/10/2023 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Direttore/Membro del Consiglio | 01/10/2023 |
Precedenti posizioni note di R. Townsend
| Società | Posizione | Fine |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2020 |
Formazione di R. Townsend
| University of Pennsylvania | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| LEXEO THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
- Borsa valori
- Insiders
- R. Townsend